ArticleResearch square2025

FOXM1 targeting alters AURKB activity and reshapes antitumor immunity to curb the progression of small cell lung cancer.

Md Arafat Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.